Propel your COVID-19 research
T cells are the adaptive immune system’s first responders to any virus, circulating in the blood to detect and quickly multiply to attack the virus, often before symptoms appear. Adaptive Biotechnologies’ unique MIRA Technology and immunoSEQ Technology have enabled us to create a comprehensive view of the T-cell response to SARS-CoV-2 infection. This data has been made public as part of the ImmuneCODE™ Initiative to help propel drug, vaccine, and clinical trial research.
The immunoSEQ T-MAP COVID offering provides tools for researchers to study the COVID-19 T-cell immune response, including detecting past SARS-CoV-2-specific immune response in research samples & the ability to track responses longitudinally.
- Researchers can search our SARS-CoV-2-specific TCR database to determine if their samples show SARS-CoV-2-specific TCRs, the antigens to which these TCR responded, and deeper insights about their samples.
- Another feature provides a simple positive or negative result that can help determine past SARS-CoV-2-specific T-cell response in research samples.